"What would it take do you think? Over $1m quarterly cashflow seems pretty impressive for a sub-$20m company with unique technology, industry tailwinds and c$2m in the bank."
Don't think you should consider $1m quarterly cash flow to be a normalised figure; it includes a government grant of $660k
And if it wasn't for the $1.8m of government grants it received over the past 2 years, the bank account would be almost empty.
So, it's a growing earnings story, but cash is yet to come out of the business because that growth requires investment in working capital:
![]()
[* Free Cash Flow = Operating Cash Flow (exc. government grants) less PP&E spend]
In essence what has been happening is that the government grants are being applied to invest in working capital (which has risen by over $1.0m over the last 2 years).
At some point, when the company reaches a position of adequate scale, the rate of working capital drag will slow and that's when the surplus capital will start to be generated. But we're not thee yet.
.
- Forums
- ASX - By Stock
- ABV
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
ABV
advanced braking technology ltd
Add to My Watchlist
1.25%
!
8.1¢

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.1¢ |
Change
0.001(1.25%) |
Mkt cap ! $32.22M |
Open | High | Low | Value | Volume |
8.0¢ | 8.1¢ | 8.0¢ | $11.81K | 146.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10128 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10128 | 0.080 |
2 | 133398 | 0.079 |
1 | 12830 | 0.078 |
1 | 23131 | 0.075 |
1 | 6781 | 0.073 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 20000 | 1 |
0.086 | 300000 | 2 |
0.088 | 7580 | 1 |
0.089 | 968103 | 1 |
0.090 | 255258 | 4 |
Last trade - 13.30pm 04/07/2025 (20 minute delay) ? |
Featured News
ABV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online